SCHEMBL3655842

SCHEMBL3655842

COC(=O)c1cc(-c2ccc(C)cc2)cc(C2(C(F)(F)F)N=NN=N2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
PDK2 Q15119 6/20 0.38
CNR2 P34972 1/20 0.37
MAPT P10636 4/20 0.37
RAB9A P51151 2/20 0.37
ALPL P05186 1/20 0.37
POLB P06746 1/20 0.37
NOTUM Q6P988 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658322 0.86 DHODH (0.44) KIF11SMN1; SMN2MAPTRAB9AALPL
SCHEMBL3654481 0.83 TDP1 (0.45) TDP1SMN1; SMN2CNR2MAPTRAB9A
SCHEMBL4054516 0.80 KIF11 (0.37) KIF11
SCHEMBL1495498 0.76 TDP1 (0.64) TDP1SMN1; SMN2CNR2MAPTRAB9A
SCHEMBL24534621 0.73 KIF11 (0.50) KIF11TDP1PDK2MAPTRAB9A
SCHEMBL13415725 0.73 CNR2 (0.60) TDP1SMN1; SMN2CNR2MAPTRAB9A
SCHEMBL21241138 0.72 TDP1 (0.69) TDP1SMN1; SMN2CNR2MAPTRAB9A
SCHEMBL12985400 0.71 PDK2 (0.46) PDK2RAB9APOLBNOTUMALDH1A1
SCHEMBL30810730 0.71 KIF11 (0.53) KIF11SMN1; SMN2PDK2RAB9ANPC1
SCHEMBL1495726 0.70 CA12 (0.61) TDP1SMN1; SMN2CNR2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed
EP-2038264-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000645-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed